Back
BioLine Rx Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
BLRX
BioLine Rx
Last Price:
0.28
Seasonality Move:
5.57%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.
BioLine Rx Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.44 | Sell |
| 20-day SMA: | 0.44 | Sell |
| 50-day SMA: | 0.49 | Sell |
| 200-day SMA: | 0.73 | Sell |
| 8-day EMA: | 0.41 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 0.49 | Sell |
| 200-day EMA: | 0.74 | Sell |
BioLine Rx Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 29.69 | Sell |
| Chaikin Money Flow: | -2669932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.49) | Sell |
| Bollinger Bands (100): | (0.46 - 0.74) | Sell |
BioLine Rx Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioLine Rx Stock
Is BioLine Rx Stock a Buy?
- BioLine Rx share price is 0.28 while BLRX 8-day simple moving average is 0.44, which is a Sell signal.
- The stock price of BLRX is 0.28 while BioLine Rx 20-day SMA is 0.44, which makes it a Sell.
- BioLine Rx 50-day simple moving average is 0.49 while BLRX share price is 0.28, making it a Sell technically.
- BLRX stock price is 0.28 and BioLine Rx 200-day simple moving average is 0.73, creating a Sell signal.
BLRX Technical Analysis vs Fundamental Analysis
Sell
32
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy or a Sell?
-
BioLine Rx stock is rated a Sell
The current BioLine Rx [BLRX] share price is $0.28. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
BioLine Rx Stock Info
Market Cap:
22.23M
Price in USD:
0.28
Share Volume:
5.86M
BioLine Rx 52-Week Range
52-Week High:
1.89
52-Week Low:
0.26
Sell
32
BioLine Rx (BLRX)
is a Sell
BioLine Rx Share Price Forecast
-
What is the BioLine Rx stock price today?
The BioLine Rx stock price is 0.28 USD today. -
Will BLRX stock go up or go down?
BioLine Rx> share price is forecast to RISE/FALL based on technical indicators -
Is BioLine Rx overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioLine Rx is overvalued.
Is BioLine Rx Stock a Buy?
- BioLine Rx share price is 0.28 while BLRX 8-day exponential moving average is 0.41, which is a Sell signal.
- The stock price of BLRX is 0.28 while BioLine Rx 20-day EMA is 0.44, which makes it a Sell.
- BioLine Rx 50-day exponential moving average is 0.49 while BLRX share price is 0.28, making it a Sell technically.
- BLRX stock price is 0.28 and BioLine Rx 200-day simple moving average is 0.74, creating a Sell signal.
Fundamental Analysis of BioLine Rx
Is BioLine Rx a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
Technical Analysis of BioLine Rx
Should I short BioLine Rx stock?
- BLRX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting BioLine Rx is a Sell
- BioLine Rx Relative Strength Index (RSI) is 29.69, which suggest BioLine Rx is oversold
- The Bollinger Bands (25) for BioLine Rx is (0.39 - 0.49), which suggest BioLine Rx is a Sell
- The Bollinger Bands (100) for BioLine Rx is (0.46 - 0.74), which suggest BioLine Rx is a Sell
* BioLine Rx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.